Literature DB >> 18310003

Maximising benefit and minimising harm of screening.

J A M Gray1, J Patnick, R G Blanks.   

Abstract

Mesh：

Year:  2008        PMID： 18310003      PMCID： PMC2258553          DOI： 10.1136/bmj.39470.643218.94

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Impact of a national external quality assessment scheme for breast pathology in the UK.

Authors:  I O Ellis; D Coleman; C Wells; S Kodikara; E M Paish; S Moss; S Al-Sam; N Anderson; L Bobrow; I Buley; C E Connolly; N S Dallimore; S Hales; A Hanby; S Humphreys; F Knox; J Lowe; J Macartney; R Nash; D Parham; J Patnick; S E Pinder; C M Quinn; A J Robertson; J Shrimankar; R A Walker; R Winder
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate.

Authors:  R G Blanks; N E Day; S M Moss
Journal:  J Med Screen       Date:  1996       Impact factor: 2.136

3.  Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer.

Authors:  P Prior; C B Woodman; S Wilson; A G Threlfall
Journal:  J Med Screen       Date:  1996       Impact factor: 2.136

4.  A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.

Authors:  R G Blanks; M G Wallis; S M Moss
Journal:  J Med Screen       Date:  1998       Impact factor: 2.136

5.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.

Authors:  R G Blanks; S M Moss; C E McGahan; M J Quinn; P J Babb
Journal:  BMJ       Date:  2000-09-16

6.  Is screening for breast cancer with mammography justifiable?

Authors:  P C Gøtzsche; O Olsen
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

7.  Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.

Authors:  J P Sloane; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; G Bussolati; D Coleman; C E Connolly; V Eusebi; C De Miguel; P Dervan; R Drijkoningen; C W Elston; D Faverly; A Gad; J Jacquemier; M Lacerda; J Martinez-Penuela; C Munt; J L Peterse; F Rank; M Sylvan; V Tsakraklides; B Zafrani
Journal:  Virchows Arch       Date:  1999-01       Impact factor: 4.064

8.  Does individual programme size affect screening performance? Results from the United Kingdom NHS breast screening programme.

Authors:  R G Blanks; R L Bennett; M G Wallis; S M Moss
Journal:  J Med Screen       Date:  2002       Impact factor: 2.136

9.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

10.  The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996-2001.

Authors:  P Sauven; H Bishop; J Patnick; J Walton; E Wheeler; G Lawrence
Journal:  Br J Surg       Date:  2003-01       Impact factor: 6.939
View more
  22 in total

1.  Value of audits in breast cancer screening quality assurance programmes.

Authors:  Tanya D Geertse; Roland Holland; Janine M H Timmers; Ellen Paap; Ruud M Pijnappel; Mireille J M Broeders; Gerard J den Heeten
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

2.  Through a glass darkly: the mammography debate.

Authors:  C Kaniklidis
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

3.  Impact of new screening technologies: should we screen and does phenotype influence this decision?

Authors:  James Robert Bonham
Journal:  J Inherit Metab Dis       Date:  2013-03-19       Impact factor: 4.982

4.  Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome.

Authors:  Cemre Robinson; Andrea Estrada; Atif Zaheer; Vikesh K Singh; Christopher L Wolfgang; Michael G Goggins; Ralph H Hruban; Laura D Wood; Michaël Noë; Elizabeth A Montgomery; Lori C Guthrie; Anne Marie Lennon; Alison M Boyce; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

5.  Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News.

Authors:  Ralph H Hruban
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

Review 6.  Early detection: the impact of genomics.

Authors:  M C J van Lanschot; L J W Bosch; M de Wit; B Carvalho; G A Meijer
Journal:  Virchows Arch       Date:  2017-06-01       Impact factor: 4.064

7.  Beyond the mammography debate: a moderate perspective.

Authors:  C Kaniklidis
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

8.  Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.

Authors:  N Pashayan; S W Duffy; S Chowdhury; T Dent; H Burton; D E Neal; D F Easton; R Eeles; P Pharoah
Journal:  Br J Cancer       Date:  2011-04-05       Impact factor: 7.640

9.  Population-based screening in the era of genomics.

Authors:  Nora Pashayan; Paul Pharoah
Journal:  Per Med       Date:  2012-06       Impact factor: 2.512

10.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.

Authors:  Michael Goggins; Kasper Alexander Overbeek; Randall Brand; Sapna Syngal; Marco Del Chiaro; Detlef K Bartsch; Claudio Bassi; Alfredo Carrato; James Farrell; Elliot K Fishman; Paul Fockens; Thomas M Gress; Jeanin E van Hooft; R H Hruban; Fay Kastrinos; Allison Klein; Anne Marie Lennon; Aimee Lucas; Walter Park; Anil Rustgi; Diane Simeone; Elena Stoffel; Hans F A Vasen; Djuna L Cahen; Marcia Irene Canto; Marco Bruno
Journal:  Gut       Date:  2019-10-31       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.